Endolumik, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$55Kgeneral payments (2019-2025)
$2,000research payments (2019-2025)
64clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2024 $7,830
2025 $47K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Surgery $50K
Obesity Medicine (Internal Medicine) $4,334
Vascular Surgery $75.00
Colon & Rectal Surgery $75.00
Surgical Oncology $75.00

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Emma Patterson Portland, OR Surgery $8,758.94
Jin Yoo Durham, NC Surgery $6,814.67
Darin Minkin Saint Louis, MO Surgery $6,100.00
Stelios Rekkas Bradenton, FL Surgery $5,500.00
Nova Szoka Morgantown, WV Obesity Medicine (Internal Medicine) $4,333.64
Lucian Panait Chaska, MN Surgery $4,166.00
Benjamin Clapp El Paso, TX Surgery $3,100.00
David Fan Bronx, NY Surgery $3,050.00
Srinivasa Gorjala Sandy Springs, GA Surgery $2,000.00
Alan Saber Cleveland, OH Surgery $1,600.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.